28 Sep, 2023 “Your parcel’s with a neighbour”: the importance of contracts with sub-processors By Mac Macmillan One of the responsibilities which processors acquired under the GDPR was to have a binding contract covering their processing which...
25 Sep, 2023 MHRA simplifies legal representative requirements for clinical investigations in Northern Ireland By Jamie Hatzel Since Brexit, the UK has been subject to two separate regulatory frameworks on medical devices. Great Britain is subject to the Medical...
25 Sep, 2023 Energy standards: when moving the goal posts is a good idea By Tim Allen Prime Minister Rishi Sunak has defended the government's decision to push back the ban on sales of new, pure petrol and diesel cars from...
22 Sep, 2023 Irides: Weekly patent litigation update By Dominic Adair Rachel Mumby Claire Phipps-Jones The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...
22 Sep, 2023 Bristows’ SnippITs - A Lidl wording makes a big difference! By Adrian Sim Naina Patel This post is part of the Bristows’ SnippITs series, which pulls together the key practical takeaways from recent court decisions for the...
21 Sep, 2023 Will Microsoft’s call of duty to restructure Activision deal pay off? By Stephen Smith Victoria Yuan Matthew Hunt James Johnston +1 more... Show less Stephen Smith, Victoria Yuan, Matthew Hunt and James Johnston discuss the CMA's Phase 1 review of the Microsoft/Activision restructured...
21 Sep, 2023 ‘Tuna bonds’ in Mozambique – Important arbitration decision from the Supreme Court on the proper approach to s.9 of the Arbitration Act 1996 By Wes Walker
21 Sep, 2023 The Innovative Devices Access Pathway – expediting access to MedTech By Alex Denoon Jamie Hatzel
20 Sep, 2023 My supplier is using AI in the delivery of its services: considerations for in-house lawyers By Rob Powell As software tools and solutions powered by AI become more prevalent and accessible, they are more frequently being used “in the...
18 Sep, 2023 First CRISPR therapy seeks regulatory approval, but will it be able to avoid the pitfalls of other cell and gene therapies? By Janna Lawrence Claire Smith Ellen Lambrix This article discusses the first CRISPR therapy seeks regulatory approval, raising the question but will it be able to avoid the pitfalls...
18 Sep, 2023 DHSC consults on statutory disclosure of industry payments to the healthcare sector By Alex Denoon Jamie Hatzel Alex Denoon, Chris Bates and Jamie Hatzel discuss the UK government's proposed statutory regime
15 Sep, 2023 Irides: Weekly patent litigation update By Dominic Adair Andrew Bowler Claire Phipps-Jones The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...